Background and Objective: Acne vulgaris is a common skin condition caused by excessive sebum production, bacterial colonization, and inflammation. The study aimed to determine the eefct of the 5% topical zinc sulfate solution on reducing the Global Acne Grading System (GAGS) score in patients with acne vulgaris. Methods: This descriptive cross-sectional study was conducted in the Department of Dermatology Jinnah Hospital, Lahore, from August 1, 2019, to February 1, 2020. A total of 100 participants fulfilling the inclusion criteria were enrolled. Pretreatment photographs were taken, and the baseline GAGS score was documented. Each patient was instructed to use 5% topical zinc sulfate twice daily on the aefcted area for 2 months. Compliance was assured by follow-up aeftr every 15 days. The participants were followed up for 2 months to assess the changes in the GAGS score. The collected data was analyzed by using Statistical Package for the Social Sciences version 25.0. A p-value of 0.05 was considered to be significant. Results: A total of 100 participants suefring from acne vulgaris were included. The mean age of the patients was 28.6 ± 6.5 years. There were 46.0% males and 54.0% females. Aeftr 2 months of use of the 5% topical zinc sulfate for acne vulgaris, 26.0% showed a good response whereas 45.0% had fair and 29.0% reported no response. Conclusion: The 5% zinc sulfate solution demonstrated a significant reduction in the GAGs score. Most responders, particularly those belonging to the disease grades I and II, exhibited a significant therapeutic response, suggesting it to be an eefctive mode of treatment for patients with mild to moderate acne.